Paper1895413
The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.
Lindsay MB and 5 others. J Urol, 1991. Cited by 190 papers, by iCite.
Cite this record
ConductScience Library. The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. Papers, record 1895413. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1895413
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Penile Induration | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Minnesota | |
| Prevalence |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AM30582 | NIADDK NIH HHS | United States | P01AM030582 | PubMed and NIH |
Source NIH RePORTER
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41777620 | Contemporary Management Strategies for Peyronie's Disease: A Comprehensive Review. | Res Rep Urol | 2026 | https://conductscience.org/library/papers/41777620 | PubMed |
| 40195592 | Peyronie's disease in the United States: A real-world, 13-year nationwide analysis of demographics, clinical characteristics, and treatment trends. | Andrology | 2025 | https://conductscience.org/library/papers/40195592 | PubMed |
| 39478653 | Diagnosis and Management of Peyronie's Disease: A Clinical Consensus Statement and Recommendations from the Korean Society for Sexual Medicine and Andrology. | World J Mens Health | 2025 | https://conductscience.org/library/papers/39478653 | PubMed |
| 38893650 | Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38893650 | PubMed |
| 38535085 | Ultrasound Elastography as a Diagnostic Tool for Peyronie's Disease: A State-of-the-Art Review. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38535085 | PubMed |
| 38228873 | Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study. | Int J Impot Res | 2024 | https://conductscience.org/library/papers/38228873 | PubMed |
| 37550385 | Safety and feasibility of percutaneous needle tunneling with platelet-rich plasma injections for Peyronie's disease in the outpatient setting: a pilot study. | Int J Impot Res | 2024 | https://conductscience.org/library/papers/37550385 | PubMed |
| 37547872 | European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease. | Sex Med | 2023 | https://conductscience.org/library/papers/37547872 | PubMed |
| 37542153 | Erectile dysfunction and Peyronie's disease diagnosis rates after penile fracture-a retrospective claims database cohort analysis. | Int J Impot Res | 2024 | https://conductscience.org/library/papers/37542153 | PubMed |
| 37198341 | The 100 most-cited publications on Peyronie's disease: a bibliometric analysis and visualization study. | Int J Impot Res | 2024 | https://conductscience.org/library/papers/37198341 | PubMed |
| 37143639 | Peyronie's Disease: A Brief Overview. | Cureus | 2023 | https://conductscience.org/library/papers/37143639 | PubMed |
| 36890295 | Commentary on diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs health care system. | Int J Impot Res | 2023 | https://conductscience.org/library/papers/36890295 | PubMed |
| 36828955 | Is there a new role for oral therapy to treat peyronie's disease? Commentary on Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's Disease: a retrospective comparative analysis. | Int J Impot Res | 2024 | https://conductscience.org/library/papers/36828955 | PubMed |
| 36614220 | The Immunological Microenvironment and the Emerging Role of Stem Cells Therapy in Peyronie's Disease: A Systematic Narrative Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36614220 | PubMed |
| 36151319 | Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system. | Int J Impot Res | 2023 | https://conductscience.org/library/papers/36151319 | PubMed |
| 35770847 | Significant familial clustering of Peyronie's disease in close and distant relatives. | Andrology | 2022 | https://conductscience.org/library/papers/35770847 | PubMed |
| 35634937 | Calcified Peyronie's Disease Frequency on Computed Tomography. | Turk J Urol | 2022 | https://conductscience.org/library/papers/35634937 | PubMed |
| 35503401 | Autologous testicular tunica vaginalis graft in Peyronie's disease: a prospective evaluation. | Int Urol Nephrol | 2022 | https://conductscience.org/library/papers/35503401 | PubMed |
| 34743193 | The potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation. | Int J Impot Res | 2022 | https://conductscience.org/library/papers/34743193 | PubMed |
| 34267363 | Canadian provider perspectives on Collagenase Clostridium histolyticum for the treatment of Peyronie's disease and the impact of its discontinuation. | Int J Impot Res | 2022 | https://conductscience.org/library/papers/34267363 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1895413
GET https://conductscience.org/api/papers/v1/1895413/cited_by?page=2